Park Avenue Center Womens is an addiction treatment center located at 2318 Park Avenue South in the 55404 zip code in Minneapolis, MN.
It is operated by a private for-profit organization. Park Avenue Center Womens provides administers naltrexone, relapse prevention from naltrexone and buprenorphine maintenance. Some of the treatment approaches used by Park Avenue Center Womens include brief intervention, motivational interviewing and relapse prevention. Park Avenue Center Womens provides outpatient methadone/buprenorphine/naltrexone treatment, partial hospitalization and intensive outpatient heroin treatment. It also provides inpatient treatment for heroin addiction and mental health diagnosis and residential heroin abuse treatment.
Here are the full facility listing details on Park Avenue Center Womens in Minneapolis, MN:
Types of Care:
- residential heroin use treatment
- inpatient treatment for heroin addiction and mental health diagnosis
Service Settings:
- outpatient heroin services
- outpatient heroin day treatment
- intensive outpatient heroin treatment program
- outpatient methadone/buprenorphine/naltrexone treatment
- regular outpatient heroin treatment
Opioid Medications used in Treatment:
- Buprenorphine treatment
- Naltrexone used in Treatment
External Opioid Medications Source:
- Personal physician/health care provider
Type of Alcohol Use Disorder Treatment:
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Administers medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment:
- Personal physician/health care provider
Type Of Treatment:
- buprenorphine maintenance
- naltrexone administration
- relapse prevention from naltrexone
Pharmacotherapies:
- Acamprosate (Campral)
- Disulfiram (Antabuse)
- Buprenorphine sub-dermal implant (Probuphine)
- Buprenorphine with naloxone (Ex. Suboxone)
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable, for example, Sublocade)
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone - Vivitrol)
- Medications for psychiatric disorders
- Medications for Hepatitis C treatment
Treatment Approaches:
- anger management
- brief intervention
- CBT
- motivational incentives
- community reinforcement
- motivational interviewing
- rational emotive behavioral therapy
- relapse prevention
- substance use counseling approach
- trauma counseling
- 12-step rehab
Facility Ownership:
- a private for-profit organization
License/Certification/Accreditation:
- State substance abuse agency
Payment/Insurance/Funding Accepted:
- Accepts private health insurance
- Accepts self payment and cash
- Accepts state health insurance
Special Programs/ Population Groups Supported:
- residential heroin rehab for adult women
- judicial clients
- dual diagnosis treatment
- people with trauma
- people with co-occurring pain plus substance use
Assessment/Pre-treatment:
- Comprehensive mental health assessment
- Comprehensive substance use assessment
Screening & Testing:
- Drug or alcohol urine screening
- Screening for mental disorders
- Screening for substance use
Transitional Services:
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
Ancillary Services:
- recovery management
- housing services
- mental health services
- self help meetings
- social skills training
- transportation assistance
- mentoring
Counseling Services and Education:
- individual counseling
- counseling for groups
- family counseling
- counseling for couples
- substance use education
- HIV/AIDS counseling
- health education services
Tobacco/Screening Services:
- Nicotine replacement therapy
- Non-nicotine smoking/tobacco cessation medications
- Smoking/tobacco cessation counseling
Facility Smoking Policy:
- Smoking permitted in designated area
Age Groups Accepted:
- adult heroin rehab
- accepts young adults over 18
Gender Accepted:
Exclusive Services:
- Specially designed program for DUI/DWI clients
